老年人亚临床甲状腺功能障碍症状:英国初级保健横断面研究
该研究嵌套于伯明翰老年甲状腺研究(BETS),在19家英国全科诊所对社区≥65岁、无显性甲状腺功能障碍或相关治疗的成人进行横断面调查,受试者在不知晓血清结果的情况下自报18种症状,并检测TSH和FT4以判定甲状腺状态。共筛查2870人,其中甲状腺功能正常2703人(94%)、亚临床甲状腺功能亢进29人(1%)、亚临床甲状腺功能减退138人(5%)。结果显示各组症状均常见,但甲状腺功能正常组与亚临床甲状腺功能减退组或亚临床甲状腺功能亢进组之间,单个症状患病率均无显著差异,多因素logistic回归也未发现单个或多个症状与亚临床状态相关。结论提示亚临床甲状腺功能障碍在老年人中不带来症状负担,支持遵循指南不治疗亚临床甲状腺功能障碍。
要点
- 老年人亚临床甲状腺功能障碍者与甲状腺功能正常者的症状患病率无显著差异。
- 多因素logistic回归未发现单个或多个症状与亚临床甲状腺状态相关。
- 全科医生可据此向有症状的老年人说明亚临床甲状腺功能障碍不太可能是原因。
核心结论
- 亚临床甲状腺功能障碍在老年人中不带来症状负担,支持遵循指南不治疗亚临床甲状腺功能障碍。
研究设计与样本
- 横断面研究,嵌套于伯明翰老年甲状腺研究(BETS),来自19家英国全科诊所。
- 研究对象为社区≥65岁、无显性甲状腺功能障碍或相关治疗的成人,在不知晓血清结果的情况下自报18种症状。
- 检测血清TSH和FT4以判定甲状腺状态。
主要发现
- 共筛查2870人:甲状腺功能正常2703人(94%)、亚临床甲状腺功能亢进29人(1%)、亚临床甲状腺功能减退138人(5%)。
- 所有组中症状均常见。
- 甲状腺功能正常组与亚临床甲状腺功能减退组之间,单个症状患病率无显著差异;与亚临床甲状腺功能亢进组比较亦无显著差异。
- 多因素logistic回归分析未发现单个或多个症状与亚临床状态相关。
临床怎么用
- 全科医生可据此向有症状的老年人说明亚临床甲状腺功能障碍不太可能是其症状的原因。
- 支持遵循指南不治疗亚临床甲状腺功能障碍。
- 持续TSH异常可能与心血管疾病长期风险相关,尤其是心房颤动,但是否应据此治疗及治疗是否改变血管结局尚不清楚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Subclinical thyroid dysfunction - abnormal serum thyrotrophin (thyroid-stimulating hormone; TSH) concentrations with normal free thyroxine (FT4) is common in older people. It remains unclear whether individuals with subclinical serum status experience an increased symptom profile. AIM: To compare the prevalence of those symptoms typically associated with overt thyroid dysfunction in older individuals with a subclinical and euthyroid serum profile. DESIGN AND SETTING: Cross-sectional study, nested within the Birmingham Elderly Thyroid Study (BETS); from 19 UK general practices. METHOD: Adults living in a community setting (aged ≥65 years), without overt thyroid dysfunction or associated treatment, self-reported the presence or absence of 18 symptoms (while serum result naïve). Serum concentrations of TSH and FT4 were measured to establish thyroid status. RESULTS: A total of 2870 individuals were screened: 2703 (94%) were categorised as euthyroid (normal), 29 (1%) subclinically hyperthyroid, and 138 (5%) subclinically hypothyroid. Symptoms were common in all groups. No significant differences in the prevalence of individual symptoms were observed between the euthyroid and subclinically hypothyroid groups nor in comparison with the subclinically hyperthyroid group. Multivariate logistic regression analysis failed to reveal an association between individual or multiple symptoms and subclinical status. CONCLUSION: Findings suggest that subclinical thyroid dysfunction does not confer a symptom burden in older individuals and support adherence to guidelines in the non-treatment of subclinical thyroid dysfunction. GPs may use the findings to reassure older people presenting with symptoms that subclinical thyroid dysfunction is an unlikely explanation. The presence of persistently abnormal TSH concentrations may be linked to long-term risks of cardiovascular disease, especially atrial fibrillation, but whether this should prompt treatment and whether such treatment alters vascular outcomes is unknown.
引用
- McCahon D, Haque MS, Parle J, et al. Subclinical thyroid dysfunction symptoms in older adults: cross-sectional study in UK primary care. Br J Gen Pract. 2020. PMID: 31932293. doi:10.3399/bjgp20X708065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。